The aim of the Test of Rapamycin in Aging Dogs (TRIAD) Cohort is to conduct a double-blind, placebo-controlled clinical trial of a drug called rapamycin (more about this in a future post). This cohort is smaller than either the Foundation or Precision Cohorts.
In order to be invited into the eligibility process, dogs must be in overall good health, at least 7 years of age, spayed or castrated, and weigh at least 44 pounds (20 kg). Owners must be willing to bring their dogs to one of the seven nationwide participating veterinary teaching hospitals twice a year. Like Foundation and Precision members, those in the TRIAD eligibility process will receive DNA and Sample Kits.
The eligibility process for TRIAD is quite involved and will take several months. Invited dogs will attend a screening visit to ensure that they have no underlying health conditions, which might prohibit their participation. Only after this screening will dogs be enrolled.
Pack members who are invited to begin the eligibility process will be given much more detailed information as the process unfolds and will be able to decline participation at any point.